Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Now that we've gone over the pharmacology of the GLP-1 agonists, let's get back to the economics.
Last time, we asked - how will the economy handle a $12,000/year drug that everyone wants?
Now we have an answer: the compounding loophole.